DICE Therapeutics, Inc.

ALKEON CAPITAL MANAGEMENT LLC

Report date

3/31/2023

Quarter

2023 Q1

Filed

5/15/2023

Shares

1,038,125

Value ($000)

29,742

Weight

0.2%

2022 Q4 - 2023 Q1 (2 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	5/15/2023	29,742	0.2%	1,038,125	3/31/2023
2022 Q4	2/14/2023	32,390	0.2%	1,038,125	12/31/2022